Supplementary Figure S2 from Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-Positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial

Eleftherios P. Mamounas,Hanna Bandos,Priya Rastogi,Yi Zhang, Kai Treuner,Peter C. Lucas,Charles E. Geyer,Louis Fehrenbacher, Stephen K. Chia,Adam M. Brufsky, Janice M. Walshe,Gamini S. Soori,Shaker Dakhil,Soonmyung Paik,Sandra M. Swain,Dennis C. Sgroi,Catherine A. Schnabel,Norman Wolmark

crossref（2024）

引用 0|浏览2

暂无评分

摘要

Supplemental Figure SF2. Exploratory Kaplan-Meier analysis based on A, any new primary cancer and B, new breast primary cancer comparing extended letrozole vs placebo in the overall Breast Cancer Index (BCI) NSABP B-42 translational cohort.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要